Marijuana Rescheduling Update: DEA Judge Allows Briefs, Declines to Reopen Hearing

Reporting credit: This article draws on National NORML’s October 22, 2026 reporting. Suncoast NORML gratefully acknowledges National NORML for its original coverage and continued work keeping cannabis consumers informed. Read National NORML’s original article here. The Florida perspective and advocacy commentary below are added by Suncoast NORML.

What happened in the marijuana rescheduling proceeding?

The DEA judge overseeing the broader marijuana rescheduling proceeding has declined to reopen the hearing for additional testimony. Instead, Administrative Law Judge Derek C. Julius will accept a Government Accountability Office report into the record and allow limited written arguments about its significance, according to National NORML.

The report concerns the DEA’s and FDA’s scheduling responsibilities and written procedures. The additional briefs will address whether its findings deserve weight and whether they affect the pending rescheduling proposal.

This procedural ruling is not a final decision on the broader marijuana rescheduling proposal.

What are the next deadlines?

National NORML reports the following schedule:

Step	Deadline
Additional briefs	October 29, 2026
Replies to those briefs	November 5, 2026

The proceeding remains stayed through the briefing period. Under the judge’s order, that stay expires when the briefing schedule concludes. That does not establish a date for a final rescheduling decision.

For the full reporting and links to the underlying documents, visit National NORML’s original coverage.

Does marijuana rescheduling mean federal legalization?

No. As National NORML explains in its Cannabis Rescheduling: Myths Versus Reality fact sheet, moving cannabis to Schedule III keeps it within the federal Controlled Substances Act.

Rescheduling and descheduling are different policy changes:

• Rescheduling moves cannabis into another controlled-substance category.

• Descheduling removes cannabis from those federal schedules.

National NORML explains that rescheduling alone does not resolve every conflict between federal law and state cannabis programs. It also does not automatically change marijuana-specific federal criminal penalties; those statutory changes require Congress.

That distinction matters when reading headlines. A procedural development, a scheduling change, and comprehensive legalization each mean something different for consumers.

Why Florida cannabis advocates should pay attention

For Suncoast NORML, this update is a reminder to keep the focus on people.

Florida’s cannabis debate should ask practical questions: Can patients afford access? Are consumers treated fairly? Do public policies protect families? Are lawmakers willing to address the consequences of prohibition?

A federal hearing cannot substitute for that work in our own communities. Florida advocates should continue pressing for patient protections, responsible adult-use policies, and the ability of medical cannabis patients to grow their own medicine.

These are Suncoast NORML’s advocacy priorities—not outcomes granted by this ruling.

Keep following the process—and keep demanding reform

The next briefing deadlines give readers concrete dates to watch. They should not be mistaken for a promise that the federal government will finish the process immediately afterward.

Our position is straightforward: cannabis consumers deserve laws grounded in evidence, fairness, and personal freedom. Progress should be measured by how policy changes improve people’s lives.

Stay connected with Suncoast NORML for cannabis policy coverage and opportunities to participate in reform.

Special thanks to National NORML: The original reporting behind this update belongs to National NORML. We encourage readers to read the complete original article, explore its educational resources, and support NORML’s national advocacy.